A

Advanced Sleep Research | Berlin, Germany

Research site

(Unclaimed)

Location

Luisenstr 54, Berlin, Berlin, Germany

Site insights

Top conditions

Top treatments

Maridebart Cafraglutide

ACT-541468

Eloralintide

Orforglipron

Tirzepatide

LY3841136

LY3298176

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 8 total trials

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight (ENLIGHTEN-3)

The purpose of the studies is to evaluate the efficacy and safety of eloralintide in participants with moderate-to-severe obstructive sleep apnea and...

Enrolling

Overweight

Sleep Apnea, Obstructive

Drug: Placebo

Drug: Eloralintide

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy (MARITIME-OSA-2)

This Phase 3 clinical trial is designed to evaluate the efficacy and safety of maridebart cafraglutide compared to placebo over a 52-week period in a...

Active, not recruiting

Obstructive Sleep Apnea

Drug: Placebo

Drug: Maridebart cafraglutide

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy (MARITIME-OSA-1)

This Phase 3 clinical trial is designed to evaluate the efficacy and safety of maridebart cafraglutide compared to placebo over a 52-week period in a...

Active, not recruiting

Obesity

Obstructive Sleep Apnea

Drug: Placebo

Drug: Maridebart cafraglutide

Trial sponsors

I

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms